Imagine trying to remove a weed from a garden without harming the delicate flowers surrounding it. This technology acts like a super-fast laser that kills the weed instantly before the surrounding flowers even realize what happened. It allows surgeons to deliver powerful radiation directly to a tumor during surgery while protecting healthy organs.
Traditional radiation therapy is often limited by the risk of damaging healthy organs surrounding a tumor. This prevents doctors from using the high doses necessary to successfully treat certain cancers, reducing patient survival rates.
A medical linear accelerator (LINAC) for intraoperative use that delivers both conventional and FLASH dose-rate radiotherapy, including an AI-powered imaging and planning unit.
If you are a surgical equipment provider dealing with the limitations of traditional radiation tools — this project developed a medical linear accelerator that delivers FLASH dose-rates to widen the therapeutic window. This allows for higher doses to tumors while keeping side effects low.
If you are a private oncology clinic dealing with tumors that cannot be treated due to their location near critical organs — this project developed an IOeRT system with 5 degrees of freedom. This ensures easier access to the anatomical region of interest in standard operating rooms.
If you are an AI medical imaging firm dealing with the need for precise treatment planning — this project developed an imaging and planning unit using artificial intelligent software. This simplifies the docking process of the accelerator through image guidance.
Based on available project data, specific pricing and cost details are not provided.
The project reached TRL8 by May 2025, indicating the system is developed and validated in its final form, which is a prerequisite for industrial scaling.
Based on available project data, the system is built on the scientific discovery of the FLASH effect, but specific patent or licensing terms are not listed.
The system is designed to be easy to handle in standard operating rooms and uses image guidance to simplify the docking process.
The project period concluded on 2025-05-31, with the system reaching TRL8 by that date.
The project is led by a single Italian SME, S.I.T. - SORDINA IORT TECHNOLOGIES SPA. With a 100% industry ratio and a single partner, the project demonstrates a highly streamlined execution focused on commercialization rather than academic research, moving rapidly from design to TRL8.
Contact S.I.T. - SORDINA IORT TECHNOLOGIES SPA in Italy
Contact us to explore licensing or partnership opportunities for this TRL8 oncology technology.
